Lipitor, Gleevec, Afrezza and Technosphere lifetime sales
Aug 8, 2014 15:00:00 GMT -5
liane, BD, and 5 more like this
Post by jpg on Aug 8, 2014 15:00:00 GMT -5
Pfizer has sold over 130 billion $ of Lipitor so far. Even off patent they are still making billions of $ off Lipitor. There was also competition for Lipitor and it is an easy to copy drug.
Afrezza and all drugs that use Technoshere will be a lot more complicated to copy once patents end (in the very distant future) and do not have any competition for the foreseeable future. This will not be ignored by BP and should be remembered every time a 'basher' says Mannkind has no sales. Lipitor had no sales till they started selling it... Those who have followed the Gleevec story know how close Novartis came to dumping Gleevec (and the pesky scientist who kept on telling them this could be a big deal drug).
www.forbes.com/sites/ycharts/2013/07/09/pfizers-projected-3b-drug-name-will-shock-you/?&_suid=14075267968740044366123620420694
I think those who say a 3-4 billion market cap is generous for Mannkind simply lack imagination of future possibilities... If Afrezza/ Technosphere is anywhere half as good a seller as Gleevec (or even better Lipitor) what market cap should we be happy with now before sales start? I personally only know at what market cap I am buying but haven't even started thinking at what point to consider selling...
JPG
Afrezza and all drugs that use Technoshere will be a lot more complicated to copy once patents end (in the very distant future) and do not have any competition for the foreseeable future. This will not be ignored by BP and should be remembered every time a 'basher' says Mannkind has no sales. Lipitor had no sales till they started selling it... Those who have followed the Gleevec story know how close Novartis came to dumping Gleevec (and the pesky scientist who kept on telling them this could be a big deal drug).
www.forbes.com/sites/ycharts/2013/07/09/pfizers-projected-3b-drug-name-will-shock-you/?&_suid=14075267968740044366123620420694
I think those who say a 3-4 billion market cap is generous for Mannkind simply lack imagination of future possibilities... If Afrezza/ Technosphere is anywhere half as good a seller as Gleevec (or even better Lipitor) what market cap should we be happy with now before sales start? I personally only know at what market cap I am buying but haven't even started thinking at what point to consider selling...
JPG
